Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent
1994-06-10
2000-02-08
Woodward, Michael P.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
435 5, 435 693, 530826, A61K 3929, C12Q 170, C12P 2102
Patent
active
060225432
ABSTRACT:
HBV surface antigen particles, prepared by recombinant DNA technology are described, said particles being composed of epitopes from the group of surface peptides and/or core peptide of non-A, non-B hepatitis virus, hepatitis virus A and/or hepatitis virus B. Respective particles are especially characterized by a composition of different epitopes selected from pre-S and S peptides. There are also described DNA-sequences, plasmids and cell lines coding for respective HBV surface antigen particles as well as a new vaccine containing the same.
REFERENCES:
patent: Re34705 (1994-08-01), Galibert et al.
patent: 3636191 (1972-01-01), Blumberg et al.
patent: 4415491 (1983-11-01), Vyas
patent: 4428941 (1984-01-01), Galibert et al.
patent: 4563423 (1986-01-01), Murray et al.
patent: 4599230 (1986-07-01), Milich et al.
patent: 4599231 (1986-07-01), Milich et al.
patent: 4639371 (1987-01-01), Prince et al.
patent: 4649192 (1987-03-01), Van Wijnendaele et al.
patent: 4683136 (1987-07-01), Milich et al.
patent: 4696898 (1987-09-01), Fitts et al.
patent: 4710463 (1987-12-01), Murray
patent: 4722840 (1988-02-01), Valenzuela et al.
patent: 4741901 (1988-05-01), Levinson et al.
patent: 4742158 (1988-05-01), Lehman et al.
patent: 4758507 (1988-07-01), Murray et al.
patent: 4777240 (1988-10-01), Moriarty et al.
patent: 4816564 (1989-03-01), Ellis et al.
patent: 4818527 (1989-04-01), Thornton et al.
patent: 4847080 (1989-07-01), Neurath et al.
patent: 4861588 (1989-08-01), Neurath et al.
patent: 4882145 (1989-11-01), Thornton et al.
patent: 4883865 (1989-11-01), Kubek
patent: 4895800 (1990-01-01), Tschopp et al.
patent: 4935235 (1990-06-01), Rutter et al.
patent: 4942125 (1990-07-01), Moriarty
patent: 4945046 (1990-07-01), Horii et al.
patent: 4959323 (1990-09-01), Acs et al.
patent: 4963483 (1990-10-01), Ellis et al.
patent: 4977092 (1990-12-01), Bitter
patent: 5011915 (1991-04-01), Yamazaki
patent: 5024938 (1991-06-01), Nozaki et al.
patent: 5039522 (1991-08-01), Neurath
patent: 5068185 (1991-11-01), Hopper et al.
patent: 5098704 (1992-03-01), Valenzuela
patent: 5102989 (1992-04-01), Sitrin et al.
patent: 5133961 (1992-07-01), Ellis et al.
patent: 5143726 (1992-09-01), Thornton et al.
patent: 5158769 (1992-10-01), Neurath et al.
patent: 5196194 (1993-03-01), Rutter et al.
patent: 5198348 (1993-03-01), Bitter
patent: 5204096 (1993-04-01), Neurath et al.
patent: 5242812 (1993-09-01), Even-Chen
patent: 5314808 (1994-05-01), Tiollais et al.
patent: 5324513 (1994-06-01), Sobczak et al.
patent: 5436139 (1995-07-01), Rutter et al.
patent: 5462863 (1995-10-01), Hsieh et al.
patent: 5565548 (1996-10-01), Neurath et al.
patent: 5591638 (1997-01-01), Tiollais et al.
patent: 5620844 (1997-04-01), Neurath et al.
Adams et al., "The Expression of Hybrid HIV:TY Virus-like Particles in Yeast," Nature, 329:68-70 (Sep. 3, 1987).
Bruss et al., "Functions of the Internal Pre-S Domain of the Large Surface Protein in Hepatitis B Virus Particle Morphogenesis," Journal of Virology, 69(11):6652-6657 (1995).
Deepen et al., "Assay of PreS Epitopes and PreS1 Antibody in Hepatitis B Virus Carriers and Immune Persons," Med. Microbiol. Immunol., 179:49-60 (1990).
Dehoux et al., "Expression of the Hepatitis B Virus Large Envelope Protein in Saccharomyces Cerevisiae," Gene, 48:155-163 (1986).
Delpeyroux et al., "Insertions in the Hepatitis B Surface Antigen Effect on Assembly and Secretion of 22-nm Particles from Mammalian Cells," J. Mol. Biol., 195:343-350 (1987).
Delpeyroux et al., "Presentation and Immungenicity of the Hepatitis B Surface Antigen and a Poliovirus Neutralization Antigen on Mixed Empty Envelope Particles," Journal of Virology, 62(5):1836-1839 (May 1988).
Dyson et al., "Selection of Peptide Inhibitors of Interactions Involved in Complex Protein Assemblies: Association of the Core and Surface Antigens of Hepatitis B Virus," Proc. Natl. Acad. Sci. USA, 92:2194-2198 (Mar. 1995).
Feitelson et al., "The Nature of Polypeptides Larger in Size than the Major Surface Antigen Components of Hepatitis B and Like Viruses in Ground Squirrels, Woodchucks, and Ducks," Virology, 130:76-90 (1983).
Francis et al., "Peptides with Added T-Cell Epitopes can Overcome Genetic Restriction of the Immune Response," CSH, pp. 9-13 (Sep. 1987) (abstract only).
Gallina et al., "A C-Terminal PreS1 Sequence is Sufficient to Retain Hepatitis B Virus L Protein in 293 Cells," Virology, 213:57-69 (1995).
Ganem et al., "The Molecular Biology of the Hepatitis B Viruses," Ann. Rev. Biochem., 56:651-693 (1987).
Good et al., "Construction of Synthetic Immunogen: Use of New T-Helper Epitope on Malaria Circumsporozoite Protein," Science, 235:1059-1062 (Feb. 27, 1987).
Heermann et al., "Large Surface Proteins of Hepatitis B Virus Containing the Pre-S Sequence," Journal of Virology, 52(2):396-402 (Nov. 1984).
Heermann et al., "Immunogenicity of the Gene S and Pre-S Domains in Hepatitis B Virions and HBsAg Filaments," Intervirology, 28:14-25 (1987).
Lo et al., "Characterization of Restriction Endonuclease Maps of Hepatitis B Viral DNAs," Biochemical and Biophysical Research Communications, 129(3):797-803 (Jun. 28, 1985).
Machein et al., "Deletion and Insertion Mutants of HBsAg Particles," Arch. Virology, 4:133-136 (1992).
Najarian et al, "Primary Structure and Gene Organization of Human Hepatitis A Virus," Proc. Nat'l. Acad. Sci., 82:2627-2631 (May 1985).
Neurath et al., "The Pre-S Region of Hepadnavirus Envelope Proteins," Academic Press, Inc., 34:65-142 (1988).
Persing et al., "The Pre S1 Protein of Hepatitis B Virus is Acylated at its Amino Terminus with Myristic Acid," Journal of Virology, pp. 1672-1677 (May 1987).
Pontisso et al., "Human Liver Plasma Membranes Contain Receptors for the Hepatitis B Virus Pre-S1 Region and, via Polymerized Human Serum Albumin, for the Pre-S2 Region," Journal of Virology, pp. 1981-1988 (May 1989).
Pontisso et al., "Identification of an Attachment Site for Human Liver Plasma Membranes on Hepatitis B Virus Particles," Virology, 173:522-530 (1989).
Prange et al., "Properties of Modified Hepatitis B Virus Surface Antigen Particles Carrying PreS Epitopes," Journal of General Virology, 76:2131-2140 (1995).
Stibbe et al., "Structural Relationships Between Minor and Major Proteins of Hepatitis B Surface Antigen," Journal of Virology, 46(2):626-628 (May 1983).
Summers et al., "Genome of Hepatitis B Virus: Restriction Enzyme Cleavage and Structure of DNA Extracted form Dane Particles," Proc. Nat. Acad. Sci. USA, 72(11):4597-4601 (Nov. 1975).
Valenzuela et al., "Antigen Engineering in Yeast: Synthesis and Assembly of Hybrid Hepatitis B Surface Antigen-herpes Simplex 1 gD Particles," Bio/Technology, 3:323-326 (Apr. 1985).
Valenzuela et al., "Synthesis and Assembly of Hepatitis B Virus Surface Antigen Particles in Yeast," Nature, 298:347-350 (Jul. 22, 1982).
Wampler et al., "Multiple Chemical Forms of Hepatitis B Surface Antigen Produced in Yeast," Proc. Natl. Acad. Sci. USA, 82:6830-6934 (Oct. 1985).
Waters et al., "A Study of the Antigenicity and Immunogenicity of a new Hepatitis B Vaccine Using a Panel of Monoclonal Antibodies," Draft (20 pages).
Wong et al., "Identification of Hepatitis B Virus Polypeptides Encoded by the Entire Pre-S Open Reading Frame," Journal of Virology, 55(1):223-231 (Jul. 1985).
Xu et al., "A Modified Hepatitis B Virus Surface Antigen with the Receptor-binding Site for Hepatocytes at its C Terminus: Expression, Antigenicity and Immunogenicity," Journal of General Virology, 75:3673-3677 (1994).
Zuckerman et al., "Immune Response to a New Hepatitis B Vaccine in Healthcare Workers who had not Responded to Standard Vaccine: Randomised Double Blind Dose-response Study," BMJ, 314:329-333 (Feb. 1, 1997).
Zuckerman et al., "Immunogenicity of a Novel Triple-S Hepatitis B Vaccine in Non-responder Healthcare Workers," Draft (22 pages).
Press Release, "Medeva PLC Announces New Positive Clinical Trial Results for Hepatitis B Product Hepagene as Vaccine and Treatment" (Oct. 16, 1997).
Dienstag et al., "Hepatitis B Vaccine Administered to Chronic Carriers of Hepatitis B Surface Antigen," Annals of Internal Medicine, 96(5):
Medeva Holdings B.V.
Woodward Michael P.
Zeman Mary K
LandOfFree
Hepatitis B surface antigen vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hepatitis B surface antigen vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis B surface antigen vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1678652